Browse by all authors Browse By Author Name - Walker,+V.

Browse Results (17 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Raynauld, J. P., Bellamy, N., Goldsmith, C. H., Tugwell, P., Torrance, G. W., Walker, V., Schultz, M., Pericak, D. and Band, P. (2000). A prospective randomized health outcomes trial of hylan G-F 20 in the treatment of patients with knee osteoarthritis. In: D.S. Pisetsky, Arthritis & Rheumatism Abstract Supplement. 2000 Annual Scientific Meeting, ACR, Philadelphia, (S340-S340). 28 Oct - 02 Nov, 2000. 83  
Raynauld, J. P., Torrance, G. W., Band, P. A., Goldsmith, C. H., Tugwell, P., Walker, V., Schultz, M. and Bellamy, N. (2002) A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis And Cartilage, 10 7: 506-517. doi:10.1053/joca.2002.0798 104   97 Cited 110 times in Scopus110 0
Torrance, G. W., Raynauld, J. P., Bellamy, N., Goldsmith, C. H., Tugwell, P., Walker, V., Schultz, M. and Band, P. (2000). A randomised trial of the effectiveness, cost effectiveness and cost utility of hylan G-F 20 for osteoarthritis of the knee. In: Abstract Book - 16th Annual Meeting of the International Society of Technology Assessment in Health Care. 16th Annual Meeting of ISTAHC, The Hague, Netherlands, (95-95). 18-21 Jun, 2000. 84  
Bellamy, N., Bell, M. J., Pericak, D., Goldsmith, C. H., Torrance, G. W., Raynauld, J. P., Walker, V., Tugwell, P. and Polisson, R. (2007) BLISS index for analyzing knee osteoarthritis trials data. Journal of Clinical Epidemiology, 60 2: 124-132. doi:10.1016/j.jclinepi.2006.04.004 58   9 Cited 10 times in Scopus10 0
Raynauld, J. P., Olszynski, W. P., Goldsmith, C. H., Torrance, G.W., Bellamy, N., Polisson, R., Pericak, D. and Walker, V. (2003). Effectiveness and safety of Hylan G-F 20 compared to steroid injections in patients with knee osteoarthritis. In: D. Pisetsky, ACR/ARHP Poster Session C. American College of Rheumatology 2003 Annual Scientific Meetig, Orlando, Florida, (S484-S484). 23-28 Oct, 2003. 74  
Raynauld, J. P., Goldsmith, C. H., Torrance, G.W., Polisson, R., Bellamy, N., Pericak, D. and Walker, V. (2003). Effectiveness and safety of hylan G-F 20 compared to steroid injections in patients with knee osteoarthritis. In: R. D. Altman, Poster Session. 8th World Congress of the OsteoArthritis Research Society Int, Berlin, Germany, (S120-S120). 12-15 Oct, 2003. 64  
Bell, M. J., Bellamy, N., Goldsmith, C. H., Tugwell, P., Torrance, G.W., Raynauld, J-P., Polisson, R., Pericak, D. and Walker, V. (2003). Evaluation of the OARSI and OMERACT-OARSI set of responder criteria in patients treated with hylan G-F 20 for knee osteoarthritis. In: D. Pisetsky, ACR/ARHP Poster Session C. American College of Rheumatology 2003 Annual Scientific Meetig, Orlando, Florida, (S482-S482). 23-28 Oct, 2003. 99  
Bellamy, N., Bell, M. J., Goldsmith, C. H., Tugwell, P., Torrance, G.W., Raynauld, J. P., Polisson, R., Pericak, D. and Walker, V. (2003). Evaluation of the OARSI and OMERACT-OARSI sets of responder criteria in patients treated with hylan G-F 20 for knee osteoarthritis. In: R. D. Altman, Poster Session. 8th World Congress of the OsteoArthritis Research Society Int, Berlin, Germany, (S80-S80). 12-15 Oct, 2003. 160  
Bellamy, N., Bell, M. J., Goldsmith, C. H., Pericak, D., Walker, V., Raynauld, J. P., Torrance, G. W., Tugwell, P. and Polisson, R. (2005) Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis. Annals of The Rheumatic Diseases, 64 6: 881-885. doi:10.1136/ard.2004.026443 91   21 Cited 20 times in Scopus20 0
Bellamy, N., Bell, M. J., Goldsmith, C. H., Torrance, G.W., Raynauld, J., Tugwell, P., Polisson, R., Pericak, D. and Walker, V. (2004). Examining minimal perceptible clinical improvement criteria in patients treated with hylan G-F-20 for knee osteoarthritis. In: L. van de Putte, Osteoarthritis - Clinical aspects and treatment. Anneual European Congress of Rheumatology EULAR, Berlin, (357-357). 9-12 Jun, 2004. 94   0
Bellamy , N., Torrance, G. W., Raynauld, J. P., Goldsmith, C. H., Tugwell, P., Walker, V., Schultz, M. and Brand, P. (2000). Health economic evaluation of hylan G-F 20 in knee osteoarthritis. In: Australian Rheumatology Associations 43rd Annual Scientific Conference - Scientific Program. Aust Rheumatology Assoc 43rd Annual Scientific Conference, Hobart, Australia, (44-44). 02-05 April, 2000. 63  
Bellamy, N., Bell, M. J., Pericak, D., Goldsmith, C. H., Torrance, G. W., Raynauld, J. P., Walker, V., Tugwell, P. and Polisson, R. (2006). Preliminary investigation of the discriminatory capacity of measures of low intensity symptom state-attainment using the WOMAC Pain Subscale score in patients treated with hylan G-F 20 for knee osteoarthritis. In: Value Health: Abstracts of ISPOR 11th Annual International Meeting. ISPOR 11th Annual International Meeting, Marriott, PA, (A28-A29). 20-24 May 2006. doi:10.1111/j.1524-4733.2006.00102_2.x 58   3
Bellamy, N., Bell, M. J., Goldsmith, C. H., Tugwell, P., Torrance, G.W., Raynauld, J. P., Polisson, R., Pericak, D. and Walker, V. (2003). Symptom free response using the WOMAC pain score in patients treated with hylan G-F 20 for knee osteoarthritis. In: R. D. Altman, Poster Session. 8th World Congress of the OsteoArthritis Research Society Int, Berlin, Germany, (S42-S42). 12-15 Oct, 2003. 105  
Torrance, G. W., Raynauld, J. P., Bellamy, N., Goldsmith, C. H., Tugwell, P., Walker, V., Schultz, M. and Band, P. (2000). The effectiveness, cost-effectiveness and cost-utility of hylan G-F 20 in osteoarthritis of the knee: Economic results. In: D. A. Gordon, Canadian Rheumatology Association, Winter Workshop & Annual Meeting. Canadian Rheumatology Association, Winter Workshop & Annual Meeting, Lake Louise, Canada, (1814-1814). 23 - 26 February 2000. 77  
Bellamy, N, Bell, MJ, Goldsmith, CH, Pericak, D, Walker, V, Raynauld, JP, Torrance, GW, Tugwell, P and Polisson, R (2005) The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI. Osteoarthritis And Cartilage, 13 2: 104-110. doi:10.1016/j.joca.2004.10.016 57   19 Cited 20 times in Scopus20 0
Bellamy, N., Bell, M. J., Goldsmith, C. H., Tugwell, P., Torrance, G.W., Raynauld, J. P., Polisson, R., Pericak, D. and Walker, V. (2003). WOMAC 20, 50, 70 response levels in patients treated with hylan G-F 20 for knee osteoarthritis. In: R. D. Altman, Poster Session. 8th World Congress of the OsteoArthritis Research Society Int, Berlin, Germany, (S82-S82). 12-15 Oct, 2003. 35  
Bellamy, N., Bell, M. J., Goldsmith, C. H., Torrance, G.W., Raynauld, J., Tugwell, P., Polisson, R., Pericak, D. and Walker, V. (2004). WOMAC 20, 50 70 response levels in patients treated with hylan G-F 20 for knee osteoarthritis. In: L. van de Putte, Osteoarthritis - Clinical aspects and treatment. Anneual European Congress of Rheumatology EULAR, Berlin, (359-359). 9-12 Jun, 2004. 45   1